Berlin, Germany, and Madrid, Spain, November 5, 2012
Companies jointly present at Medica, November 14-17, 2012, in Düsseldorf
SCIENION AG and GENOMICA S.A.Unipersonal, today announced the expansion of their strategic partnership. Both companies will offer to the life science market a jointly developed new printing plate technology platform. This new platform combines SCIENION’s non-contact arraying and surface technologies with GENOMICA’s multiplex PCR technology and microarrays detection. Both enterprises will advance in the development of new molecular applications, among which, in vitro diagnostics and personalized medicine will lead the way.
Berlin, Germany, and Madrid, Spain, November 5, 2012
San Diego, CA, and Berlin, Germany, September 19, 2012
• Scienion’s Automated Liquid Handling Dispenser Complements the Simplicity, Speed and Flexibility of the Maverick Multiplexed System • New Genalyte Custom Spotting Service Enables Maverick Customers to Obtain Ready-to-Use Arrays Designed to Their Specifications • To Learn More About Genalyte and Scienion, Visit Booth 26 at Lab-On-A-Chip 2012 World Congress September 25-26 in San Diego, CA Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, and Scienion AG, a life science company developing microarray and ultra-low volume liquid handling systems, today announced an agreement under which Genalyte will market Scienion’s sciFLEXARRAYER™ automated liquid dispensers along with Genalyte’s multiplexed Maverick™ Detection System.
Dortmund and Berlin, Germany, September 10, 2012
SCIENION AG and Maine Manufacturing, LLC, today announced an agreement on SCIENION’s marketing of Maine Manufacturing’s FAST® protein array products. The non-exclusive distribution arrangement includes the worldwide marketing of the complete FAST® Slide product line.
Dortmund and Berlin, Germany, June 25, 2012
PRINCETON, N. J., USA, and Berlin, Germany, June 25, 2012 — SCIENION US, Inc. today announced that Courtagen Life Sciences, Inc. – a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry – will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.
Dortmund and Berlin, Germany, May 25, 2012
Scienion launches the new version of its sciFLEXARRAYER S1 at European Lab Automation in Hamburg, May 30-31. The small compact non-contact piezo dispensing roboter with an increased throughput and versatility offers precise ultra-low volume liquid handling for a variety of applications in multiplexed diagnostics and cellular screening approaches.
Dortmund and Berlin, Germany, March 20, 2012
SCIENION AG today announced the introduction of its sciREADER CL for colorimetric detection of multiplex assays. With the sciREADER Scienion extends its product portfolio in order to provide customers with best quality equipment for total multiplexing solutions.
Dortmund and Berlin, Germany, December 6, 2011
SCIENION AG today announced the foundation of an US subsidiary in Princeton, New Jersey. In the year of its tenth company anniversary Scienion starts selling its products and services directly into the North American market. Dr. Holger Eickhoff, CEO of Scienion AG, stated: “After having started our US activities five years ago with an US-based distributor, now our business in this key market is growing to an extent that we decided to build our own base with a Scienion subsidiary in New Jersey. This step is a consequence of increasing demands not only for our sciFLEXARRAYER dispensers but also for our contract manufacturing services. Thus, we will also establish a contract manufacturing unit in North America. I am sure our North American customers will benefit from our presence in the US.”
Dortmund and Berlin, October 6, 2011
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. SCIENION AG today announced that the planned acquisition by Canadian SQI Diagnostics Inc. will not be realized. The share purchase agreement was terminated.
Dortmund and Berlin, Germany, July 4, 2011
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. Scienion AG, a German-based microarray manufacturing equipment and microarray print and development services company today announced that it has entered into an agreement to be acquired by SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. SQI will acquire all of the share capital of Scienion AG.
Dortmund and Darmstadt, Germany, June 27, 2011
SCIENION AG today has announced that R-Biopharm AG – a leading developer of products for clinical diagnostics and food & feed analysis – will use SCIENION’s sciFLEXARRAYER technology to produce innovative chips for the detection of antibiotic residues in milk.Read more…
Dortmund and Berlin, Germany, April 19, 2011
Scienion AG today announced that the company will produce protein microarray batches for clinical validation studies of proprietary biomarker panels of Protagen AG. The batch sizes will comprise more than 1000 arrays. Additionally, both companies plan to jointly evaluate new platforms for multiplex analytics and to co-develop novel approaches up to proof-of-concept levels under a strategic partnership.